Metabolites
Clinivex provides a specialized collection of certified pharmaceutical metabolite standards synthesized to support the characterization, quantification, and safety assessment of drug biotransformation products throughout the pharmaceutical development continuum. From Phase I oxidative metabolites and Phase II conjugates to reactive intermediates and pharmacologically active metabolites, our catalog addresses the full metabolic landscape encountered during in vitro ADME studies, in vivo pharmacokinetic investigations, and regulatory metabolite profiling programs. Serving drug discovery teams, bioanalytical CROs, and pharmaceutical QC laboratories across the USA and international regulated environments, Clinivex delivers metabolite reference materials with the chemical integrity and documentation quality that modern regulatory submissions demand.
Showing 1–16 of 1107 results
Authentic Pharmaceutical Metabolite Standards for ADME Profiling, Safety Testing, and Regulatory Submissions
Clinivex stocks an expansive range of pharmaceutical metabolite standards spanning major therapeutic categories, including cardiovascular agents, CNS compounds, anti-infectives, oncology drugs, and immunomodulators, covering hydroxylated, glucuronidated, sulfated, N-oxide, and N-dealkylated metabolite forms that routinely emerge from CYP450-mediated and non-CYP biotransformation pathways. These authenticated reference compounds are indispensable for metabolite identification and structural confirmation by LC-HRMS and NMR, absolute quantification in plasma and urine matrices using validated LC-MS/MS bioanalytical methods, and disproportionate metabolite assessment required under the FDA MIST guidance and ICH M3(R2) framework. Each standard undergoes comprehensive characterization encompassing chemical purity determination, structural identity verification, and chiral purity assessment – ensuring your metabolite data package meets the evidentiary standard expected by FDA, EMA, and PMDA reviewers. For related drug substance metabolite workflows in preclinical safety evaluation, our drug metabolite reference standards catalog extends coverage to glucuronides, sulfates, N-oxides, and conjugative metabolites across a broad spectrum of therapeutic classes.
Every pharmaceutical metabolite standard from Clinivex is released with a detailed Certificate of Analysis (CoA) that documents purity, structural confirmation, solvent system, concentration, and storage stability, aligned with GLP documentation principles and ICH Q2(R1) analytical validation requirements. Sourced from ISO-compliant and GMP-experienced synthetic partners with proven track records in complex metabolite synthesis, our reference materials offer the batch consistency and regulatory traceability your bioanalytical validation studies and safety qualification reports require. For internal standard solutions to pair with your metabolite quantification assays, our stable isotope labelled standards provide isotopically enriched counterparts that enhance assay accuracy in complex biological matrices. Engage our technical team early in your program to ensure the right metabolite standards are secured for your specific drug candidate and study design.
why Choose Clinivex?
At Clinivex, we earn trust by delivering impeccable service, expert guidance, and reliable solutions that drive long-term success. With a skilled team and customer-first approach, we stand as a leading pharmaceutical reference standards supplier in the USA and Canada.
Dedicated Towards Betterment
Driven by innovation, committed to progress.
One-Stop Product Source
All-in-one destination for trusted scientific solutions.
Where Trust Meets Innovation
Blending trust, accuracy, and innovation for groundbreaking results.
Fast and Courteous Customer Service
Merging reliability, accuracy, and innovation to redefine excellence.
Have questions? Get in touch!
Just fill in your details and our representatives will get back to you soon!
Join other members of the R&D community getting the latest news, information and guides.
